Pharmacokinetics of Low Molecular Weight Heparin and Unfractionated Heparin in Pregnancy

被引：0
|
作者：
Mary H. H. Ensom
Mary D. Stephenson
机构：
[1] University of British Columbia,Faculty of Pharmaceutical Sciences and Department of Obstetrics and Gynaecology
[2] British Columbia’s Women’s Hospital & Health Centre and British Columbia’s Research Institute for Children’s & Women’s Health,Reproductive Medicine Program
[3] OB7,Department of Pharmacy
[4] BC Women’s Hospital & Health Centre,undefined
来源：
The Journal of the Society for Gynecologic Investigation: JSGI | 2004年 / 11卷
关键词：
Antiphospholipid antibody syndrome; dalteparin; unfractionated heparin; pharmacokinetics; pregnancy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：377 / 383
页数：6
相关论文
共 50 条
  • [31] Effect of low-molecular-weight heparin (Tinzaparin) and unfractionated heparin on platelet aggregation
    Ravn, HB
    Bregengaard, C
    Vissinger, H
    Ostergaard, P
    Holst, J
    Nielsen, HK
    Kristensen, SD
    Husted, SE
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (03) : 209 - 212
  • [32] Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer
    Akl, Elie A.
    Kahale, Lara
    Sperati, Francesca
    Neumann, Ignacio
    Labedi, Nawman
    Terrenato, Irene
    Barba, Maddalena
    Sempos, Elena V.
    Muti, Paola
    Cook, Deborah
    Schuenemann, Holger
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (06):
  • [33] Comparison of low-molecular-weight-heparin and unfractionated heparin for acute PTE.
    Chen L.Y.
    Ying K.J.
    Hong W.J.
    Zhou P.
    Journal of Zhejiang University SCIENCE B, 2005, 6 (12): : 1195 - 1199
  • [34] HEPARIN AND FIBRINOLYSIS - COMPARISON OF SUBCUTANEOUS ADMINISTRATION OF UNFRACTIONATED AND LOW-MOLECULAR WEIGHT HEPARIN
    ERIKSSON, E
    WOLLTER, IM
    CHRISTENSON, B
    STIGENDAL, L
    RISBERG, B
    THROMBOSIS AND HAEMOSTASIS, 1988, 59 (02) : 284 - 288
  • [35] Bleeding Risk of Therapeutic Unfractionated Heparin and Low Molecular Weight Heparin in Patients with Cirrhosis
    Katherine L. Summers
    Kyle A. Davis
    Sarah A. Nisly
    Clinical Drug Investigation, 2020, 40 : 191 - 196
  • [36] Fixed-dose unfractionated heparin vs low-molecular-weight heparin
    Edwards, Jonathan Lee
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (03): : 262 - 262
  • [37] Effects of a low molecular weight heparin, Bemiparin, and unfractionated heparin on hemostatic properties of endothelium
    Pérez-Ruiz, A
    Montes, R
    Carrasco, P
    Rocha, E
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2002, 8 (01) : 65 - 71
  • [38] DELAYED CUTANEOUS REACTION TO UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARIN AND DANAPAROID
    SIVAKUMARAN, M
    GHOSH, K
    MUNKS, R
    GELSTHORPE, K
    TAN, L
    WOOD, JK
    BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (04) : 893 - 894
  • [39] Prophylactic Low-Molecular-Weight Heparin Versus Unfractionated Heparin at the Time of Delivery
    Pluym, Ilina D.
    Holliman, Kerry
    Bermudez, Ana
    Afshar, Yalda
    Silverman, Neil S.
    Rao, Rashmi
    OBSTETRICS AND GYNECOLOGY, 2020, 135 : 132S - 132S
  • [40] Low-molecular-weight heparin vs unfractionated heparin in acute coronary syndromes
    Schreiber, Richard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (20): : 2353 - 2353
12345